The story frames this as a breakthrough in brain cancer treatment with a broad goal of expanding access to effective therapies while minimizing side effects, and highlights it as a significant upcoming multi-institutional clinical trial.

Additional context is available through MADE FOR THIS and Duke’s tumor biology resources.

The approach is particularly impactful for children, with the potential to shrink tumors and possibly avoid radiation to spare long-term brain damage.

Duke plans the LIMITLESS trial, a multi-institutional study to evaluate safety and efficacy for treating brain metastases.

A novel method uses low-frequency ultrasound and microbubbles to transiently open the blood-brain barrier, enabling chemotherapy to reach brain tumors through a targeted, minimally invasive approach.

The technique employs IV microbubbles activated by focused ultrasound to create openings in brain vessels, allowing deeper drug delivery and potentially reducing chemotherapy toxicity by targeting the tumor area, led by Duke neurosurgeon Dr. Gerald Grant.

This is a point-in-time report; readers should view the full article for comprehensive details.